Agilon Health Inc. (AGL) Tops Q1 EPS by 288c ; Offers Guidance

Agilon Health Inc. (NYSE: AGL) reported Q1 EPS of $2.94, $2.88 better than the analyst estimate of $0.06. Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.41 billion.

FY 2026 Outlook:-

Revenue between $5.68 billion to $5.81 billion vs consensus $5.46 billion.

Q2 2026 outlook:-

Revenue between $1.44 billion to $1.48 billion vs consensus $1.35 billion.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
• BofA lists top 5 themes driving next $1tn in incremental semi sales